Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection

Pharmaceutical Statistics(2021)10.1002/pst.2125Source: DataRank Database

A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection is a research paper published in Pharmaceutical Statistics (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.21)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Susan Halabi ORCID,Sandipan Dutta ORCID

Live enrichment

PubMed:33855778 PMC:PMC8514582 OpenAlex:https://openalex.org/W3154640064

National Institutes of Health

Grant: R21 CA195424‐01

National Institutes of Health

Grant: R01 CA256157‐01

U.S. Army Medical Research Acquisition Activity

Grant: W81XWH‐15‐1‐0467

U.S. Army Medical Research Acquisition Activity

Grant: W81XWH‐18‐1‐0278

NCI NIH HHS

Grant: R01 CA256157

NCI NIH HHS

Grant: R21 CA195424

National Institutes of Health

Grant: 1R21CA195424-01

Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer

National Institutes of Health

Grant: 5R01CA256157-04

Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC

PCF

FWCI

0.21

Citation Percentile

0.5%

Citation Trend

2024

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8514582

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2125

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/pst.2125

publisherhttps://onlinelibrary.wiley.com/doi/am-pdf/10.1002/pst.2125

Fields of Study

Statistical Methods in Clinical TrialsStatistical Methods and InferenceAdvanced Causal Inference Techniques01 natural sciences03 medical and health sciences0302 clinical medicine0101 mathematics

MeSH Terms

Computer SimulationHumansMaleModels, StatisticalBiomarkersLimit of Detection

Keywords

Parametric statisticsSemiparametric regressionSemiparametric modelTobit modelNonparametric statisticsProstate cancerLimit (mathematics)StatisticsComputer scienceBiomarkerParametric modelEconometricsMathematicsMedicineCancerInternal medicineBiologyBiomarkersLimit Of DetectionCensored RegressionSemi-parametric ModelPseudo-valueMaleModels, StatisticalCardiologyPharmaceutics and Drug DesignLimit of reductionOncologyPharmaceutical PreparationsHumansComputer SimulationPseudo value

Sustainable Development Goals

SDG 0: Good health and well-being